SG Americas Securities
ALDR

SG Americas Securities’s Alder Biopharmaceuticals ALDR Stock Holding History

SG Americas Securities’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-28,959
Closed -$341K – 3370
2019
Q2 		$341K Buy
+28,959
New +$351K ﹤0.01% 2124
2018
Q3 		– Sell
-6,781
Closed -$107K – 3617
2018
Q2 		$107K Buy
+6,781
New +$103K ﹤0.01% 3033
2018
Q1 		– Sell
-11,561
Closed -$132K – 3698
2017
Q4 		$132K Buy
+11,561
New +$129K ﹤0.01% 2704
2017
Q3 		– Sell
-15,580
Closed -$178K – 3840
2017
Q2 		$178K Buy
15,580
+8,140
+109% +$150K ﹤0.01% 2527
2017
Q1 		$155K Sell
7,440
-14,323
-66% -$317K ﹤0.01% 2638
2016
Q4 		$453K Buy
21,763
+18,516
+570% +$481K ﹤0.01% 1768
2016
Q3 		$106K Buy
+3,247
New +$98.9K ﹤0.01% 3034
2016
Q2 		– Sell
-7,323
Closed -$179K – 3165
2016
Q1 		$179K Buy
+7,323
New +$170K ﹤0.01% 2269
2015
Q4 		– Sell
-7,481
Closed -$245K – 3100
2015
Q3 		$245K Buy
+7,481
New +$318K ﹤0.01% 1326
2015
Q2 		– Sell
-4,255
Closed -$123K – 2943
2015
Q1 		$123K Sell
4,255
-124
-3% -$3.4K ﹤0.01% 2155
2014
Q4 		$127K Buy
+4,379
New +$78.6K ﹤0.01% 2763

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SG Americas Securities's ALDR Position: Q3 2019 in Review

SG Americas Securities sold out of Alder Biopharmaceuticals (ALDR) in Q3 2019, closing a stake of 28,959 shares — an estimated $341K sold.

SG Americas Securities first reported a position in ALDR in Q4 2014 and held it in 11 quarters. The position peaked at $453K in Q4 2016. 143 funds tracked by Wall St. Rank hold ALDR as of Q3 2019.

  • SG Americas Securities reported no remaining Alder Biopharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • SG Americas Securities sold 28,959 Alder Biopharmaceuticals shares in Q3 2019, an estimated $341K.
  • SG Americas Securities first reported a position in Alder Biopharmaceuticals in Q4 2014 and held it in 11 quarters.
  • SG Americas Securities's Alder Biopharmaceuticals position peaked at $453K in Q4 2016.
  • 143 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2019.

Based on SG Americas Securities's 13F filing for Q3 2019, filed 4 Nov 2019.